Advertisement

Nutritional Considerations for Adolescents with Chronic Kidney Disease

  • Lisa Keung
Chapter

Abstract

The dietitian plays a vital role in the multidisciplinary care of a child with chronic kidney disease (CKD). The dietitian’s role specifically is to ensure that each child’s nutritional status is optimized to promote adequate growth in the setting of CKD.

This chapter reviews the dietitian’s approach to interpreting growth parameters, laboratory values, common medications used in CKD, and dietary history. Using this information, an individualized nutritional plan is developed which is used as educational material to engage the family and child to optimize their nutritional intake in the setting of CKD.

Keywords

Growth Nutrition Chronic kidney disease 

References

  1. 1.
    Tonshoff B, Mehls O. Growth retardation in children with chronic renal insufficiency: current aspects of pathophysiology and treatment. J Nephrol. 1995;8:133.Google Scholar
  2. 2.
    Tom A, McCauley L, Bell L, Rodd C, Espinosa P, Yu G, et al. Growth during maintenance hemodialysis: impact of enhanced nutrition and clearance. J Pediatr. 1999;134(4):464–71.CrossRefGoogle Scholar
  3. 3.
    Kari J, Gonzalez C, Ledermann S, Shaw V, Rees L. Outcome and growth of infants with severe chronic renal failure. Kidney Int. 2000;57(4):1681–7.CrossRefGoogle Scholar
  4. 4.
    Boirie Y, Broyer M, Gagnadoux M, Niaudet P, Bresson J. Alterations of protein metabolism by metabolic acidosis in children with chronic renal failure. Kidney Int. 2000;58(1):236–41.CrossRefGoogle Scholar
  5. 5.
    Tonshoff B, Kiepe D, Ciarmatori S. Growth hormone/insulin-like growth factor system in children with chronic renal failure. Pediatr Nephrol. 2005;20(3):279–89.CrossRefGoogle Scholar
  6. 6.
    Hamiwka L, Midgley J, Wade A, Martz K, Grisaru S. Outcomes of kidney transplantation in children with nephronophthisis: an analysis of the North American pediatric renal trials and collaborative studies (NAPRTCS) registry. Pediatr Transplant. 2008;12(8):878–82.CrossRefGoogle Scholar
  7. 7.
    Massengill S, Ferris M. Chronic kidney disease in children and adolescents. Pediatr Rev. 2014;35(1):16–29.CrossRefGoogle Scholar
  8. 8.
    Tanner J, Goldstein H, Whitehouse R. Standards for children’s height at ages 2-9 years allowing for height of parents. Arch Dis Child. 1970;45(244):755–62.CrossRefGoogle Scholar
  9. 9.
    Legler J, Rose L. Assessment of abnormal growth curves. Am Fam Physician. 1998;58(1):153–8.PubMedGoogle Scholar
  10. 10.
    Mahan J, Warady B. Assessment and treatment of short stature in pediatric patients with chronic kidney disease: a consensus statement. Pediatr Nephrol. 2006;21(7):917–30.CrossRefGoogle Scholar
  11. 11.
    Ogden C, Carroll M, Lawman H, Fryar C, Kruszon-Moran D, Kit B, et al. Trends in obesity prevalence among children and adolescents in the United States, 1988–1994 through 2013–2014. JAMA. 2016;315(21):2292.CrossRefGoogle Scholar
  12. 12.
    Ding W. Impact of obesity on kidney function and blood pressure in children. World J Nephrol. 2015;4(2):223.CrossRefGoogle Scholar
  13. 13.
    Green Corkins K. Nutrition-focused physical examination in pediatric patients. Nutr Clin Pract. 2015;30(2):203–9.CrossRefGoogle Scholar
  14. 14.
    Isakova T, Nickolas T, Denburg M, Yarlagadda S, Weiner D, Gutiérrez O, et al. KDOQI US commentary on the 2017 KDIGO clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease–mineral and bone disorder (CKD-MBD). Am J Kidney Dis. 2017;70(6):737–51.CrossRefGoogle Scholar
  15. 15.
    Parpia AS, L’Abbe M, Goldstein M, Arcand J, Magnuson B, Darling PB. The impact of additives on the phosphorus, potassium, and sodium content of commonly consumed meat, poultry, and fish products among patients with chronic kidney disease. J Ren Nutr. 2018;28(2):83–90.CrossRefGoogle Scholar
  16. 16.
    Carrigan A, Klinger A, Choquette S, Luzuriaga-McPherson A, Bell E, Darnell B, et al. Contribution of food additives to sodium and phosphorus content of diets rich in processed foods. J Ren Nutr. 2014;24(1):13–19.e1.CrossRefGoogle Scholar
  17. 17.
    National Kidney Foundation. KDOQI clinical practice guideline for nutrition in children with CKD: 2008 update. Am J Kidney Dis. 2009;53(3):S11–S104.CrossRefGoogle Scholar
  18. 18.
    Jones C, Akbani H, Croft D, Worth D. The relationship between serum albumin and hydration status in hemodialysis patients. J Ren Nutr. 2002;12(4):209–12.CrossRefGoogle Scholar
  19. 19.
    Kaysen G, Dubin J, Müller H, Mitch W, Rosales L, Levin N, et al. Relationships among inflammation nutrition and physiologic mechanisms establishing albumin levels in hemodialysis patients. Kidney Int. 2002;61(6):2240–9.CrossRefGoogle Scholar
  20. 20.
    Srivaths P, Wong C, Goldstein S. Nutrition aspects in children receiving maintenance hemodialysis: impact on outcome. Pediatr Nephrol. 2008;24(5):951–7.CrossRefGoogle Scholar
  21. 21.
    Goldstein S, Baronette S, Gambrell T, Currier H, Brewer E. nPCR assessment and IDPN treatment of malnutrition in pediatric hemodialysis patients. Pediatr Nephrol. 2002;17(7):531–4.CrossRefGoogle Scholar
  22. 22.
    Orellana P, Juarez-Congelosi M, Goldstein S. Intradialytic parenteral nutrition treatment and biochemical marker assessment for malnutrition in adolescent maintenance hemodialysis patients. J Ren Nutr. 2005;15(3):312–7.CrossRefGoogle Scholar
  23. 23.
    Juarez-Congelosi M, Orellana P, Goldstein S. Normalized protein catabolic rate versus serum albumin as a nutrition status marker in pediatric patients receiving hemodialysis. J Ren Nutr. 2007;17(4):269–74.CrossRefGoogle Scholar
  24. 24.
    Nelson S, Sarabia S, Christilaw E, Ward E, Lynch S, Adams M, et al. Phosphate-containing prescription medications contribute to the daily phosphate intake in a third of hemodialysis patients. J Ren Nutr. 2017;27(2):91–6.CrossRefGoogle Scholar
  25. 25.
    Liu C, Shang Y, Zhang X, Zhang X, Wang B, Wu Z, et al. Co-administration of grapefruit juice increases bioavailability of tacrolimus in liver transplant patients: a prospective study. Eur J Clin Pharmacol. 2009;65(9):881–5.CrossRefGoogle Scholar
  26. 26.
    Khuu T, Hickey A, Deng M. Pomegranate-containing products and tacrolimus: a potential interaction. J Heart Lung Transplant. 2013;32(2):272–4.CrossRefGoogle Scholar
  27. 27.
    Barlow S. Expert committee recommendations regarding the prevention, assessment, and treatment of child and adolescent overweight and obesity: summary report. Pediatrics. 2007;120(Supplement 4):S164–92.CrossRefGoogle Scholar
  28. 28.
    David LA, Maurice CF, Carmody RN, Gootenberg DB, Button JE, Wolfe BE, et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature. 2014;505(7484):559–63.CrossRefGoogle Scholar
  29. 29.
    Schulman G, Berl T, Beck G, Remuzzi G, Ritz E, Arita K, et al. Randomized placebo-controlled EPPIC trials of AST-120 in CKD. J Am Soc Nephrol. 2014;26(7):1732–46.CrossRefGoogle Scholar
  30. 30.
    Couluris M, Mayer J, Freyer D, Sandler E, Xu P, Krischer J. The effect of cyproheptadine hydrochloride (Periactin) and megestrol acetate (Megace) on weight in children with cancer/treatment-related cachexia. J Pediatr Hematol Oncol. 2008;30(11):791–7.CrossRefGoogle Scholar
  31. 31.
    Summerbell C, Youle M, McDonald V, Catalan J, Gazzard B. Megestrol acetate vs cyproheptadine in the treatment of weight loss associated with HIV infection. Int J STD AIDS. 1992;3(4):278–80.CrossRefGoogle Scholar
  32. 32.
    Homnick D, Homnick B, Reeves A, Marks J, Pimentel R, Bonnema S. Cyproheptadine is an effective appetite stimulant in cystic fibrosis. Pediatr Pulmonol. 2004;38(2):129–34.CrossRefGoogle Scholar
  33. 33.
    Homnick D, Marks J, Hare K, Bonnema S. Long-term trial of cyproheptadine as an appetite stimulant in cystic fibrosis. Pediatr Pulmonol. 2005;40(3):251–6.CrossRefGoogle Scholar
  34. 34.
    Hobbs D, Bunchman T, Weismantel D, Cole M, Ferguson K, Gast T, et al. Megestrol acetate improves weight gain in pediatric patients with chronic kidney disease. J Ren Nutr. 2010;20(6):408–13.CrossRefGoogle Scholar
  35. 35.
  36. 36.

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.University of CaliforniaSan FranciscoUSA

Personalised recommendations